Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Can J Diabetes ; 48(1): 3-9.e7, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37549869

RESUMEN

OBJECTIVE: People living with diabetes mellitus (DM) and chronic kidney disease can have difficulty attending multiple appointments to receive DM care. We developed and studied the utility of a DM outreach program to offer in the hemodialysis (HD) unit. METHODS: We conducted a quality improvement project in a satellite HD unit in London, Ontario, Canada, between August 1, 2019, and July 31, 2022. We assessed for baseline gaps in DM care among those with DM, performed root-cause analysis with key stakeholders to identify critical drivers of gaps, and conceptualized a certified diabetes educator-led outreach program to offer in the HD unit. We aimed to improve DM self-monitoring, hypo- and hyperglycemia, and DM-related screening. We used run and control charts to track outcome measures over time and modified our outreach program iteratively. RESULTS: Fifty-eight persons with DM receiving HD participated in our program. Support spanned multiple waves of the COVID-19 pandemic. With 4 tests of change, we observed improvement in DM self-monitoring with a modest decline in self-reported hyperglycemia. There were no adverse consequences, and satisfaction with our program was high. CONCLUSIONS: Although we did not meet all measures of success during the pandemic, outreach DM support in the HD unit appeared to improve self-monitoring and self-reported hyperglycemia. Similar programs could be modified and implemented in other centres.


Asunto(s)
COVID-19 , Diabetes Mellitus Tipo 2 , Hiperglucemia , Humanos , Diabetes Mellitus Tipo 2/etiología , Pandemias , Diálisis Renal/efectos adversos , Unidades de Hemodiálisis en Hospital , Mejoramiento de la Calidad , COVID-19/epidemiología , Hiperglucemia/epidemiología , Hiperglucemia/prevención & control , Hiperglucemia/etiología , Ontario/epidemiología
2.
Mol Biol Rep ; 50(7): 6087-6096, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37300745

RESUMEN

BACKGROUND: Single nucleotide polymorphism (SNPs) in BRCA1, BRCA2 and TP53 has been widely associated with breast cancer risk in different ethnicities with inconsistent results. There is no such study conducted so far in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. Therefore, this study was conducted to check BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan. METHODS: This study, consisting 140 breast cancer patients and 80 gender and age matched healthy controls were subjected to confirm BRCA1, BRCA2 and TP53 polymorphism. Clinicopathological data and blood samples were taken from all the participants. DNA was extracted and SNPs were confirmed using T-ARMS-PCR protocol. RESULTS: Our data indicated that BRCA1, BRCA2, and TP53 selected SNPs risk allele and risk allele containing genotypes displayed significant association (p < 0.05) with breast cancer risk in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. CONCLUSION: All the three selected SNPs of BRCA1, BRCA2 and TP53 showed significant association with breast cancer risk in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. However, more investigation will be required on large data sets to confirm the selected SNPs and other SNPs in the selected and other related genes with the risk of breast cancer.


Asunto(s)
Neoplasias de la Mama , Humanos , Femenino , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/genética , Predisposición Genética a la Enfermedad , Pakistán , Genotipo , Polimorfismo de Nucleótido Simple/genética , Proteína p53 Supresora de Tumor/genética , Proteína BRCA1/genética , Proteína BRCA2/genética
3.
Front Immunol ; 14: 1091941, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36776835

RESUMEN

Introduction: The current monkeypox (MPX) outbreak, caused by the monkeypox virus (MPXV), has turned into a global concern, with over 59,000 infection cases and 23 deaths worldwide. Objectives: Herein, we aimed to exploit robust immunoinformatics approach, targeting membrane-bound, enveloped, and extracellular proteins of MPXV to formulate a chimeric antigen. Such a strategy could similarly be applied for identifying immunodominant epitopes and designing multi-epitope vaccine ensembles in other pathogens responsible for chronic pathologies that are difficult to intervene against. Methods: A reverse vaccinology pipeline was used to select 11 potential vaccine candidates, which were screened and mapped to predict immunodominant B-cell and T-cell epitopes. The finalized epitopes were merged with the aid of suitable linkers, an adjuvant (Resuscitation-promoting factor), a PADRE sequence (13 aa), and an HIV TAT sequence (11 aa) to formulate a multivalent epitope vaccine. Bioinformatics tools were employed to carry out codon adaptation and computational cloning. The tertiary structure of the chimeric vaccine construct was modeled via I-TASSER, and its interaction with Toll-like receptor 4 (TLR4) was evaluated using molecular docking and molecular dynamics simulation. C-ImmSim server was implemented to examine the immune response against the designed multi-epitope antigen. Results and discussion: The designed chimeric vaccine construct included 21 immunodominant epitopes (six B-cell, eight cytotoxic T lymphocyte, and seven helper T-lymphocyte) and is predicted non-allergen, antigenic, soluble, with suitable physicochemical features, that can promote cross-protection among the MPXV strains. The selected epitopes indicated a wide global population coverage (93.62%). Most finalized epitopes have 70%-100% sequence similarity with the experimentally validated immune epitopes of the vaccinia virus, which can be helpful in the speedy progression of vaccine design. Lastly, molecular docking and molecular dynamics simulation computed stable and energetically favourable interaction between the putative antigen and TLR4. Conclusion: Our results show that the multi-epitope vaccine might elicit cellular and humoral immune responses and could be a potential vaccine candidate against the MPXV infection. Further experimental testing of the proposed vaccine is warranted to validate its safety and efficacy profile.


Asunto(s)
Monkeypox virus , Receptor Toll-Like 4 , Vacunas Virales , Epítopos de Linfocito B , Epítopos Inmunodominantes/genética , Simulación del Acoplamiento Molecular , Vacunas Combinadas , Vacunas Virales/inmunología
4.
J Pak Med Assoc ; 63(3): 310-2, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23914626

RESUMEN

OBJECTIVE: To assess and compare changes in pulmonary functions before and after exercise in young healthy adults. METHODS: The case-control study was carried out from January to March 2010 on 292 medical students aged 18-24 years at Bahria University Medical and Dental College, Karachi. Baseline values for forced expiratory volume (FEV1) and forced vital capacity (FVC) were measured with a digital spirometer, and the FEV1: FVC ratio was calculated. The lung functions of group I comprising 192 volunteers after aerobic exercise of 30 minutes daily, for five days over eight weeks, was compared with group II having 100 controls who did not participate in any physical activity. SPSS 15 was used for statistical analysis. RESULT: At the end of eight weeks, there was a significant rise in FEV1 (2.49 +/- 0.82 to 2.59 +/- 0.79 liters), decline in FVC (2.80 +/- 0.92 to 2.7 +/- 0.87 liters) and an increase in the FEV1: FVC ratio (89.52 +/-12.66 to 95.56 +/- 13.42) in group I students. CONCLUSION: Improvement in pulmonary functions was noticed as a result of physical activity.


Asunto(s)
Volumen Espiratorio Forzado/fisiología , Actividad Motora/fisiología , Capacidad Vital/fisiología , Adolescente , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Espirometría , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...